Sir Pascal Soriot (pictured) is reportedly weighing the move for the drugs giant amid growing frustration with the UK’s rules on approving new medicines.Read More
You might also be interested in reading Pundit Sounds Major Crash Alarm For XRP Price As ’12-Year Cycle’ Comes To An End.